DIN 02394936 — SEEBRI BREEZHALER 50 MCG
SEEBRI BREEZHALER is a capsule of Glycopyrronium marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Glycopyrronium monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02394936
- Brand name
- SEEBRI BREEZHALER
- Active ingredient
- Glycopyrronium
- Strength
- 50 MCG
- Dosage form
- CAPSULE
- Route
- INHALATION
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Long-acting muscarinic antagonist (LAMA) inhaled bronchodilator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.